Since the early stages of the COVID-19 pandemic, researchers at Virginia Commonwealth University's School of Medicine have maintained a national database of patients affected by COVID-19-related smell loss. Their latest survey shows that more than half of respondents are still impacted by smell dysfunction five years after initial infection.
Over 50% of COVID-19 Patients Experience Long-Term Smell Loss, Study Reveals
Researchers at Virginia Commonwealth University found that over 50% of individuals who experienced smell loss due to COVID-19 still have symptoms five years post-infection. This study highlights the long-term effects of COVID-19, which could inform public health responses in Iran. Understanding these impacts is crucial for addressing ongoing health challenges in the country.
👥 Key Players
📰 What Happened
Researchers at Virginia Commonwealth University found that over 50% of individuals who experienced smell loss due to COVID-19 still have symptoms five years post-infection. This indicates significant long-term effects of the virus.
- More than half of COVID-19 patients report long-term smell dysfunction.
- The study is based on a national database maintained since the early pandemic.
💡 Why It Matters
📚 Background
COVID-19 has led to various long-term health issues, including smell loss, which affects quality of life. Understanding these effects is essential for developing effective health policies.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%